Zhenhua H. Lin

Longjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Cholangiocarcinoma:Unveiling the cold tumor microenvironment and strategies for immune rejuvenation.

Cholangiocarcinoma:Unveiling the cold tumor microenvironment and strategies for immune rejuvenation.

Journal: Oncogene

Published: January 27, 2026

Metal Nanoparticles as Sensitizers in Energy-Based Therapies for Lung Cancer: From Mechanistic Insights to Clinical Translation.

Metal Nanoparticles as Sensitizers in Energy-Based Therapies for Lung Cancer: From Mechanistic Insights to Clinical Translation.

Journal: International journal of nanomedicine

Published: January 07, 2026

Ferroptosis in lung cancer: Emerging mechanisms, therapeutic targeting, and immune modulation.

Ferroptosis in lung cancer: Emerging mechanisms, therapeutic targeting, and immune modulation.

Journal: Cellular signalling

Published: November 06, 2025

Ferroptosis in lung cancer: Emerging mechanisms, therapeutic targeting, and immune modulation.

Ferroptosis in lung cancer: Emerging mechanisms, therapeutic targeting, and immune modulation.

Journal: Cellular signalling

Published: November 06, 2025

QD394 induces ferroptosis and suppresses the proliferation of colorectal cancer via the SP1/JNK pathway.

QD394 induces ferroptosis and suppresses the proliferation of colorectal cancer via the SP1/JNK pathway.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 16, 2025

Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1α-SIX1 axis.

Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1α-SIX1 axis.

Journal: iScience

Published: October 16, 2025

Advances in ovarian cancer: biological insights, therapeutic innovations, and future perspectives.

Advances in ovarian cancer: biological insights, therapeutic innovations, and future perspectives.

Journal: Journal of ovarian research

Published: August 04, 2025

Corrigendum to "CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway" [Cell Signalling 135 (2025) 111998].

Corrigendum to "CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway" [Cell Signalling 135 (2025) 111998].

Journal: Cellular signalling

Published: August 03, 2025

Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic opportunities.

Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic opportunities.

Journal: Cellular signalling

Published: July 25, 2025

Lenalidomide for adult Langerhans cell histiocytosis: a report of 4 cases

Lenalidomide for adult Langerhans cell histiocytosis: a report of 4 cases

Journal: Zhonghua nei ke za zhi

Published: June 08, 2025

Exploring the mechanism of Levistolide A in the treatment of lung cancer cells based on network analysis, molecular docking and experimental validation.

Exploring the mechanism of Levistolide A in the treatment of lung cancer cells based on network analysis, molecular docking and experimental validation.

Journal: Bioorganic chemistry

Published: April 18, 2025

CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway.

CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway.

Journal: Cellular signalling

Published: April 06, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026